This inventor holds 1 USPTO granted patent. Top assignee: Sail Biomedicines. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anna Blois: Innovator in AHR Antagonists
Introduction
Anna Blois is a prominent inventor based in Chestnut Hill, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the aryl hydrocarbon receptor (AHR). Her work is crucial in addressing various diseases, including cancer.
Latest Patents
Anna Blois holds a patent for "Fused imidazole derivatives as AHR antagonists." This patent encompasses compounds of formulae (I)-(VI) and their pharmaceutically acceptable salts. The disclosure details pharmaceutical compositions that include these compounds, methods for their preparation, and their application in treating or preventing diseases associated with dysregulated immune responses or aberrant AHR signaling.
Career Highlights
Throughout her career, Anna has focused on innovative solutions in the pharmaceutical industry. Her research has led to advancements in the treatment of conditions linked to AHR signaling, showcasing her dedication to improving health outcomes.
Collaborations
Anna Blois has collaborated with notable colleagues, including Bernard Lanter and Alessandra Bartolozzi. These partnerships have enhanced her research efforts and contributed to the success of her projects.
Conclusion
Anna Blois is a key figure in the development of AHR antagonists, with her patent reflecting her innovative approach to addressing critical health issues. Her work continues to influence the pharmaceutical landscape positively.